{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:37:46Z","timestamp":1762508266717,"version":"3.37.3"},"reference-count":35,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["8015"],"award-info":[{"award-number":["8015"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IDDT"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Leishmaniasis is a public health problem and endemic in countries of the tropics and subtropics. An ongoing project with naked LACK (Leishmania homolog of receptors for activated C-kinase) demonstrated that this case of the gene is entirely susceptible to immune response and it does enter the cells effectively. This study aimed at developing a procedure to prepare a type of lipid nanoparticles overloaded with plasmid LACK (pcLACK) for usage as Leishmania major (L. major) nanoliposomal vaccine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods:<\/jats:title><jats:p>The single-gene expression plasmid of pcLACK was encoded in the LACK antigen. Nanoparticles were set up by thin film procedure using cationic lipids 1, 2-Dioleoyl- 3-Trimethylammonium propane (DOTAP), 1, 2-Dioleoyl-snGlycero-3-Phosphoethanolamine (DOPE), and cholesterol in a molar proportion of 2:1:1 molar ratio. Using dynamic light scattering, the particle diameters of empty and loaded lipoplexes were measured in triplicate. The zeta-potential (\u03b6) was measured with the same instrument using the zeta potential mode as the average of 20 measurements by diluting the particles into a low salt buffer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The results of the sustainability studies of Liposome-pcLACK formulation showed that there were no significant physical changes up to the 30th day of stability study at the storage condition of 4\u00b0C. However, there were significant changes in the formulation content during storage at 25\u00b0C for 30 days (204.2\u00b10.90 at Day 30 compared with 207.2\u00b10.26 nm at Day 0). It was observed that the prepared nanoliposomal formulation had more stability under refrigeration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Immunostimulatory cationic lipids bearing a pcLACK encapsulation could serve as an effective delivery system.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871526520666201005141159","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T05:41:49Z","timestamp":1601962909000},"page":"527-533","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preparation and Characterization of A Nanoliposomal Vaccine of pcLACK Candidate Against Cutaneous Leishmaniasis"],"prefix":"10.2174","volume":"21","author":[{"given":"Hajar Ziaei","family":"Hezarjaribi","sequence":"first","affiliation":[{"name":"Toxoplasmosis Research Center, Iranian National Registry Center for Toxoplasmosis(INRCT), School of Medicine, Mazandaran University of Medical Sciences, Sari,Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5566-0060","authenticated-orcid":true,"given":"Masoud","family":"Soosaraei","sequence":"additional","affiliation":[{"name":"Toxoplasmosis Research Center, Iranian National Registry Center for Toxoplasmosis(INRCT), School of Medicine, Mazandaran University of Medical Sciences, Sari,Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Fakhar","sequence":"additional","affiliation":[{"name":"Toxoplasmosis Research Center, Iranian National Registry Center for Toxoplasmosis(INRCT), School of Medicine, Mazandaran University of Medical Sciences, Sari,Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Akhtari","sequence":"additional","affiliation":[{"name":"Toxoplasmosis Research Center, Iranian National Registry Center for Toxoplasmosis(INRCT), School of Medicine, Mazandaran University of Medical Sciences, Sari,Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Rafiei","sequence":"additional","affiliation":[{"name":"Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari,Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oghol Niaz","family":"Jorjani","sequence":"additional","affiliation":[{"name":"Laboratory Science Research Center, Golestan University of Medical Sciences, Gorgan,Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1166\/jbn.2017.2349","volume":"13","author":"de Almeida L.","year":"2017","unstructured":"de Almeida L.; Terumi Fujimura A.; Del Cistia M.L.; Fonseca-Santos B.; Braga Imamura K.; Michels P.A.M.; Chorilli M.; Graminha M.A.S.; Nanotechnological Strategies for Treatment of Leishmaniasis--A Review. J Biomed Nanotechnol 2017,13(2),117-133","journal-title":"J Biomed Nanotechnol"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7555\/JBR.27.20120064","volume":"27","author":"Mutiso J.M.","year":"2013","unstructured":"Mutiso J.M.; Macharia J.C.; Kiio M.N.; Ichagichu J.M.; Rikoi H.; Gicheru M.M.; Development of Leishmania vaccines: predicting the future from past and present experience. J Biomed Res 2013,27(2),85-102","journal-title":"J Biomed Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"Alvar J.","year":"2012","unstructured":"Alvar J.; V&#xE9;lez I.D.; Bern C.; Herrero M.; Desjeux P.; Cano J.; Jannin J.; den Boer M.; Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012,7(5),e35671","journal-title":"PLoS One"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","volume":"366","author":"Murray H.W.","year":"2005","unstructured":"Murray H.W.; Berman J.D.; Davies C.R.; Saravia N.G.; Advances in leishmaniasis. Lancet 2005,366(9496),1561-1577","journal-title":"Lancet"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/ng2053","volume":"39","author":"Peacock C.S.","year":"2007","unstructured":"Peacock C.S.; Seeger K.; Harris D.; Murphy L.; Ruiz J.C.; Quail M.A.; Peters N.; Adlem E.; Tivey A.; Aslett M.; Kerhornou A.; Ivens A.; Fraser A.; Rajandream M.A.; Carver T.; Norbertczak H.; Chillingworth T.; Hance Z.; Jagels K.; Moule S.; Ormond D.; Rutter S.; Squares R.; Whitehead S.; Rabbinowitsch E.; Arrowsmith C.; White B.; Thurston S.; Bringaud F.; Baldauf S.L.; Faulconbridge A.; Jeffares D.; Depledge D.P.; Oyola S.O.; Hilley J.D.; Brito L.O.; Tosi L.R.; Barrell B.; Cruz A.K.; Mottram J.C.; Smith D.F.; Berriman M.; Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 2007,39(7),839-847","journal-title":"Nat Genet"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00436-008-0943-2","volume":"103","author":"Santos D.O.","year":"2008","unstructured":"Santos D.O.; Coutinho C.E.; Madeira M.F.; Bottino C.G.; Vieira R.T.; Nascimento S.B.; Bernardino A.; Bourguignon S.C.; Corte-Real S.; Pinho R.T.; Rodrigues C.R.; Castro H.C.; Leishmaniasis treatment--a challenge that remains: a review. Parasitol Res 2008,103(1),1-10","journal-title":"Parasitol Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","volume":"19","author":"Croft S.L.","year":"2003","unstructured":"Croft S.L.; Coombs G.H.; Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol 2003,19(11),502-508","journal-title":"Trends Parasitol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1590\/1806-9282.64.03.281","volume":"64","author":"Anversa L.","year":"2018","unstructured":"Anversa L.; Tiburcio M.G.S.; Richini-Pereira V.B.; Ramirez L.E.; Human leishmaniasis in Brazil: A general review. Rev Assoc Med Bras (1992) 2018,64(3),281-289","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.exppara.2013.03.012","volume":"134","author":"Hezarjaribi H.Z.","year":"2013","unstructured":"Hezarjaribi H.Z.; Ghaffarifar F.; Dalimi A.; Sharifi Z.; Jorjani O.; Effect of IL-22 on DNA vaccine encoding LACK gene of Leishmania major in BALB\/c mice. Exp Parasitol 2013,134(3),341-348","journal-title":"Exp Parasitol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2015.03.017","volume":"422","author":"Jain K.","year":"2015","unstructured":"Jain K.; Jain N.K.; Vaccines for visceral leishmaniasis: A review. J Immunol Methods 2015,422,1-12","journal-title":"J Immunol Methods"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<762::AID-IMMU762>3.0.CO;2-4","volume":"29","author":"Courret N.","year":"1999","unstructured":"Courret N.; Prina E.; Mougneau E.; Saraiva E.M.; Sacks D.L.; Glaichenhaus N.; Antoine J.C.; Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur J Immunol 1999,29(3),762-773","journal-title":"Eur J Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1038\/sj.onc.1204778","volume":"20","author":"Schechtman D.","year":"2001","unstructured":"Schechtman D.; Mochly-Rosen D.; Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 2001,20(44),6339-6347","journal-title":"Oncogene"},{"journal-title":"Plasmids for therapy and vaccination Schleef, M","year":"2008","key":"ref=13","unstructured":"Plasmids for therapy and vaccination Schleef, M 2008"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ni0504-460","volume":"5","author":"Levine M.M.","year":"2004","unstructured":"Levine M.M.; Sztein M.B.; Vaccine development strategies for improving immunization: the role of modern immunology. Nat Immunol 2004,5(5),460-464","journal-title":"Nat Immunol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jbiotec.2012.08.012","volume":"162","author":"Li L.","year":"2012","unstructured":"Li L.; Saade F.; Petrovsky N.; The future of human DNA vaccines. J Biotechnol 2012,162(2-3),171-182","journal-title":"J Biotechnol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","volume":"239","author":"Liu M.A.","year":"2011","unstructured":"Liu M.A.; DNA vaccines: an historical perspective and view to the future. Immunol Rev 2011,239(1),62-84","journal-title":"Immunol Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1166\/jbn.2014.1981","volume":"10","author":"Shah M.A.","year":"2014","unstructured":"Shah M.A.; He N.; Li Z.; Ali Z.; Zhang L.; Nanoparticles for DNA vaccine delivery. J Biomed Nanotechnol 2014,10(9),2332-2349","journal-title":"J Biomed Nanotechnol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.aah6157","volume":"353","author":"Abbink P.","year":"2016","unstructured":"Abbink P.; Larocca R.A.; De La Barrera R.A.; Bricault C.A.; Moseley E.T.; Boyd M.; Kirilova M.; Li Z.; Ng\u2019ang\u2019a D.; Nanayakkara O.; Nityanandam R.; Mercado N.B.; Borducchi E.N.; Agarwal A.; Brinkman A.L.; Cabral C.; Chandrashekar A.; Giglio P.B.; Jetton D.; Jimenez J.; Lee B.C.; Mojta S.; Molloy K.; Shetty M.; Neubauer G.H.; Stephenson K.E.; Peron J.P.; Zanotto P.M.; Misamore J.; Finneyfrock B.; Lewis M.G.; Alter G.; Modjarrad K.; Jarman R.G.; Eckels K.H.; Michael N.L.; Thomas S.J.; Barouch D.H.; Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science 2016,353(6304),1129-1132","journal-title":"Science"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11259-008-9040-3","volume":"32","author":"Dhama K.","year":"2008","unstructured":"Dhama K.; Mahendran M.; Gupta P.K.; Rai A.; DNA vaccines and their applications in veterinary practice: current perspectives. Vet Res Commun 2008,32(5),341-356","journal-title":"Vet Res Commun"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.21775\/cimb.022.079","volume":"22","author":"Myhr A.I.","year":"2017","unstructured":"Myhr A.I.; DNA vaccines: regulatory considerations and safety aspects. Curr Issues Mol Biol 2017,22,79-88","journal-title":"Curr Issues Mol Biol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/vaccines3010186","volume":"3","author":"Nakayama Y.","year":"2015","unstructured":"Nakayama Y.; Aruga A.; Comparison of current regulatory status for gene-based vaccines in the US, europe and japan. Vaccines (Basel) 2015,3(1),186-202","journal-title":"Vaccines (Basel)"},{"key":"ref=22","first-page":"1665","volume":"4","author":"Gurram I.","year":"2017","unstructured":"Gurram I.; Kavitha M.V.; Nagabhushnam M.V.; Bonthagara B.; Reddy D.N.; Overview of validation, basic concepts and analytical method process validation. Indo Am J Pharm Sci 2017,4(6),1665-1680","journal-title":"Indo Am J Pharm Sci"},{"key":"ref=23","first-page":"914","volume":"7","author":"Kanuri P.","year":"2016","unstructured":"Kanuri P.; Science and risk based approach to the process validation. link from quality by design to process validation. Int J Pharm Sci Res 2016,7(3),914-929","journal-title":"Int J Pharm Sci Res"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0141-0229(03)00205-9","volume":"33","author":"Rathore A.S.","year":"2003","unstructured":"Rathore A.S.; Li X.; Bartkowski W.; Yeboah S.; Sharma A.; Case study and application of process analytical technology (PAT) towards bioprocessing: Use of tryptophan DNA for vaccine and gene therapy: plasmid design, production, and purification. Enzyme Microb Technol 2003,33,865-883","journal-title":"Enzyme Microb Technol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1586\/14760584.2016.1124762","volume":"15","author":"Li L","year":"2016","unstructured":"Li L; Petrovsky N; Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev Vaccines 2016,15(3),313-329","journal-title":"Expert Rev Vaccines"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/02648725.2016.1178011","volume":"31","author":"\u0160im&#x10D;&#xED;kov&#xE1; M.","year":"2015","unstructured":"\u0160im&#x10D;&#xED;kov&#xE1; M.; Prather K.L.; Prazeres D.M.; Monteiro G.A.; Towards effective non-viral gene delivery vector. Biotechnol Genet Eng Rev 2015,31(1-2),82-107","journal-title":"Biotechnol Genet Eng Rev"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/adma.200801478","volume":"21","author":"Nguyen D.N.","year":"2009","unstructured":"Nguyen D.N.; Green J.J.; Chan J.M.; Longer R.; Anderson D.G.; Polymeric materials for gene delivery and DNA vaccination. Adv Mater 2009,21(8),847-867","journal-title":"Adv Mater"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.7774\/cevr.2015.4.1.1","author":"Grunwald T","year":"2015","unstructured":"Grunwald T; Ulbert S.; Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases 2015","journal-title":"Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13273-014-0001-3","volume":"10","author":"Choi Y.S.","year":"2014","unstructured":"Choi Y.S.; Lee M.Y.; David A.E.; Park Y.S.; Nanoparticles for gene delivery: therapeutic and toxic effects. Mol Cell Toxicol 2014,10(1),1-8","journal-title":"Mol Cell Toxicol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejps.2017.03.023","volume":"102","author":"Inoh Y.","year":"2017","unstructured":"Inoh Y.; Nagai M.; Matsushita K.; Nakanishi M.; Furuno T.; Gene transfection efficiency into dendritic cells is influenced by the size of cationic liposomes\/DNA complexes. Eur J Pharm Sci 2017,102,230-236","journal-title":"Eur J Pharm Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1389-0344(01)00101-0","volume":"18","author":"O\u2019Hagan D.T.","year":"2001","unstructured":"O\u2019Hagan D.T.; MacKichan M.L.; Singh M.; Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng 2001,18(3),69-85","journal-title":"Biomol Eng"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.msec.2017.02.012","volume":"75","author":"Rasoulianboroujeni M.","year":"2017","unstructured":"Rasoulianboroujeni M.; Kupgan G.; Moghadam F.; Tahriri M.; Boughdachi A.; Khoshkenar P.; Ambrose J.J.; Kiaie N.; Vashaee D.; Ramsey J.D.; Tayebi L.; Development of a DNA-liposome complex for gene delivery applications. Mater Sci Eng C 2017,75,191-197","journal-title":"Mater Sci Eng C"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jconrel.2009.10.022","volume":"142","author":"Henriksen-Lacey M.","year":"2010","unstructured":"Henriksen-Lacey M.; Bramwell V.W.; Christensen D.; Agger E.M.; Andersen P.; Perrie Y.; Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen. J Control Release 2010,142(2),180-186","journal-title":"J Control Release"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.fuel.2018.08.070","volume":"235","author":"Ure&#xF1;a-B&#xFA;rquez L.A.","year":"2019","unstructured":"Ure&#xF1;a-B&#xFA;rquez L.A.; Garc&#xED;a-Rend&#xF3;n A.; Roch&#xED;n-Wong S.; Tejeda-Mansir A.; Preparation and characterization of a nanovaccine of pVAX1-NH36 for leishmaniasis. Fuel 2019,235,1077-1082","journal-title":"Fuel"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","volume":"15","author":"Lee S.","year":"2015","unstructured":"Lee S.; Nguyen M.T.; Recent advances of vaccine adjuvants for infectious diseases. Immune Netw 2015,15(2),51-57","journal-title":"Immune Netw"}],"container-title":["Infectious Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/186606","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/186606\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/186606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T03:13:14Z","timestamp":1696821194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/186606\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871526520666201005141159","relation":{},"ISSN":["1871-5265"],"issn-type":[{"type":"print","value":"1871-5265"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}